Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of zolbetuximab in pancreatic cancer models.
Türeci Ӧ, Mitnacht-Kraus R, Wöll S, Yamada T, Sahin U. Türeci Ӧ, et al. Among authors: woll s. Oncoimmunology. 2018 Nov 10;8(1):e1523096. doi: 10.1080/2162402X.2018.1523096. eCollection 2019. Oncoimmunology. 2018. PMID: 30546962 Free PMC article.
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.
Reinhard K, Rengstl B, Oehm P, Michel K, Billmeier A, Hayduk N, Klein O, Kuna K, Ouchan Y, Wöll S, Christ E, Weber D, Suchan M, Bukur T, Birtel M, Jahndel V, Mroz K, Hobohm K, Kranz L, Diken M, Kühlcke K, Türeci Ö, Sahin U. Reinhard K, et al. Among authors: woll s. Science. 2020 Jan 24;367(6476):446-453. doi: 10.1126/science.aay5967. Epub 2020 Jan 2. Science. 2020. PMID: 31896660
PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation.
Roldán DB, Grimmler M, Hartmann C, Hubich-Rau S, Beißert T, Paret C, Cagna G, Rohde C, Wöll S, Koslowski M, Türeci Ö, Sahin U. Roldán DB, et al. Among authors: woll s. Oncotarget. 2020 May 19;11(20):1862-1875. doi: 10.18632/oncotarget.27582. eCollection 2020 May 19. Oncotarget. 2020. PMID: 32499871 Free PMC article.
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG, Lyu SI, Laible M, Wöll S, Türeci Ö, Şahin U, Alakus H, Fahrig L, Zander T, Buettner R, Bruns CJ, Schroeder W, Gebauer F, Quaas A. Simon AG, et al. Among authors: woll s. J Transl Med. 2023 Aug 17;21(1):552. doi: 10.1186/s12967-023-04433-8. J Transl Med. 2023. PMID: 37592303 Free PMC article.
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody.
Bähr-Mahmud H, Ellinghaus U, Stadler CR, Fischer L, Lindemann C, Chaturvedi A, Diekmann J, Wöll S, Biermann I, Hebich B, Scharf C, Siefke M, Roth AS, Rao M, Brettschneider K, Ewen EM, Şahin U, Türeci Ö. Bähr-Mahmud H, et al. Among authors: woll s. Oncoimmunology. 2023 Oct 16;12(1):2255041. doi: 10.1080/2162402X.2023.2255041. eCollection 2023. Oncoimmunology. 2023. PMID: 37860278 Free PMC article.
41 results